BEVZ92
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BEVZ92, covering 2019-07-23 to 2019-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients [Phase 1]